vascuCAP vs Rapid RV/LV
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A (vascuCAP) is designed for comprehensive plaque analysis and cardiovascular risk stratification from CT angiography, focusing on atherosclerotic disease. Tool B (Rapid RV/LV) specializes in the rapid assessment of pulmonary embolism severity by measuring right and left ventricle ratios from CTPA scans. While both are FDA-cleared AI tools for cardiovascular imaging analysis, their distinct clinical targets make them suitable for different diagnostic pathways.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
vascuCAP (now ElucidVivo/PlaqueIQ) is designed for non-invasive CT angiography analysis, quantifying plaque composition and assessing cardiovascular risk to optimize treatment decisions for conditions like stroke and heart attack. Rapid RV/LV is an AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans.
vascuCAP quantifies lipid-rich necrotic core, calcification, non-calcified matrix, and intraplaque hemorrhage, offering histologically-validated plaque quantification and characterization. Rapid RV/LV automatically measures right and left ventricle diameters and calculates the RV/LV ratio, which is a key indicator of pulmonary embolism severity.
Both vascuCAP and Rapid RV/LV support Cardiology and Radiology. Additionally, vascuCAP is relevant for Vascular Surgery, while Rapid RV/LV also supports Pulmonology.
vascuCAP performs AI-enabled analysis of non-invasive CT angiograms. Rapid RV/LV analyzes CTPA (Computed Tomography Pulmonary Angiogram) images to assess pulmonary embolism severity.
vascuCAP offers DICOM integration and PACS/EMR interoperability. Rapid RV/LV integrates with the broader Rapid PE solution and provides triage and notification capabilities as part of the Rapid platform.
vascuCAP provides 3D visualization of arterial vessels and plaque, risk stratification for stroke and heart attack, and support for personalized treatment decisions. Rapid RV/LV delivers rapid results (within minutes of scan) with annotated images showing ventricular measurements, and aims to reduce inter-rater variability.